Concepedia
Circulation · 2010 · 200 citations · 42 references
Open access
These results establish MG53 as a primary component of the cardiac IPC response, thus identifying a potentially important novel therapeutic target for the treatment of ischemic heart disease.
42
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Charles E. Murry, Robert B. Jennings, K A Reimer · Circulation · 1986 · 7.8K citations · Full text
Animal Physiology, Ischemic Myocardium, Cardiovascular Disease +14
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
Christopher J L Murray, Alan D López · The Lancet · 1997 · 7K citations
Cause 1990–2020, Health Systems, Global Burden +13
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Alexei Degterev, Zhihong Huang, Michael Boyce et al. · Nature Chemical Biology · 2005 · 3K citations
Apoptosis, Cell Death, Pharmacotherapy +16
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning
Zhi‐Qing Zhao, Joel S. Corvera, Michael E. Halkos et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2003 · 2K citations
Percutaneous Coronary Intervention, Ischemic Preconditioning, Repetitive Ischemia +14
Akt Promotes Survival of Cardiomyocytes In Vitro and Protects Against Ischemia-Reperfusion Injury in Mouse Heart
Yasushi Fujio, Thao Nguyen, Detlef Wencker et al. · Circulation · 2000 · 839 citations · Full text